The Food and Drug Administration last night said that Moderna can add up to 50% more doses per vial of its COVID-19 vaccine. Moderna had been shipping 10-dose vials; the FDA’s change will enable shipments to contain up to 15 doses per vial. 

In doing so, FDA also will permit vaccinators to extract an eleventh dose from existing 10-dose vials. 

Such a change is contingent on the availability of certain syringes and needles. Read the FDA’s updated provider fact sheet for more details.

Meanwhile, the Centers for Disease Control and Prevention today loosened federal guidance on travel during the COVID-19 pandemic, stating that fully vaccinated individuals can resume domestic and international travel. 

CDC recommends these individuals continue to wear masks in public but domestic travelers do not need to get tested for COVID-19 before and after travel, nor do they need to self-quarantine afterwards. International travelers should have a negative COVID-19 test within 3 to 5 days upon return.
 

Related News Articles

Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…